You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Relvar 100 and 200

Relvar Ellipta

RELVAR ELLIPTA is an ICS/LABA combination for the treatment of asthma and COPD. 1 Relvar is the only ICS/LABA which delivers 24 hours of continuous efficacy from just one daily inhalation 1

Find out more

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline group of companies.
Relvar Ellipta was developed in collaboration with Innoviva Inc

All images are for illustration purposes only.